Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > Dr. Foster> Italian cruise ship captain...
View:
Post by ISAloser247 on Jun 07, 2012 5:54pm

Dr. Foster> Italian cruise ship captain...

...much like the ARROGANT and NARCISSTIC captain of the Costa Concordia, Francesco Schettino, the good doctor has driven ISA onto the rocks, and it is sinking fast.  FIVE point FIVE CENTS a share.  Will we ever know what Iljin was offering for more control?  What was the BEST for shareholders?  Re - publishing old studies, re - appearing on the Home Shopping Channel, pathetically repeating the same  actions from a decade ago, desparately trying to find new suckers to prop up the house of cards! Don't think it has ever looked this grim! Where o where has snrkid, narcissist, thrumud, macbethorfaust gone ?
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities